Stock Comparison
ABBV vs BMY
AbbVie Inc and Bristol-Myers Squibb Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$131.77B
P/E (TTM)
70.3
14.2
Forward P/E
17.7
9.4
Price/Sales
6.8
2.7
Price/Book
51.1
5.9
EV/EBITDA
25.8
9.9
Dividend Yield
2.03%
2.91%
Profitability
Net Margin
9.82%
15.01%
Operating Margin
29.77%
25.67%
Return on Equity
62.30%
46.60%
Return on Assets
10.50%
10.70%
Growth (YoY)
Revenue Growth
10.20%
5.70%
Earnings Growth
290.40%
153.10%
Price & Risk
Beta
0.3
0.2
52-Week High
$263.65
$65.90
52-Week Low
$197.38
$41.66
Analyst Target
$274.36
$66.21
Compare ABBV and BMY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.